To investigate levels of oxysterols in healthy control (HC) and multiple sclerosis (MS) patients and their interdependence with demographic, clinical characteristics, and cholesterol biomarkers.
Methods:
This study included 550 subjects (203 HC, 221 relapsing–remitting MS (RR-MS), 126 progressive MS (P-MS)). A complete lipid profile including total cholesterol (TC); high-density lipoprotein–cholesterol (HDL-C); low-density lipoprotein–cholesterol (LDL-C); apolipoproteins (Apo) A1, A2, B, and E; C-reactive protein (CRP); 24-hydroxycholesterol (HC); 25-HC; 27-HC; 7α-HC; and 7-ketocholesterol (KC) was obtained. Lipoprotein particle sizing by proton nuclear magnetic resonance (H1 NMR) was available for 432 subjects.
Results:
The levels of 24-HC, 27-HC, and 7α-HC (all p < 0.015) were lower in MS compared to HC, and 7-KC was higher in P-MS compared to RR-MS (p < 0.001). TC, LDL-C, and ApoB were associated with higher levels of all oxysterols (all p < 0.05) in HC. In MS, LDL-C was associated with higher levels of 24-HC, 25-HC, 7-KC, and 7α-HC (all p < 0.05), while TC and ApoB were associated with increased levels of all oxysterols (all p < 0.005).
Conclusion:
The findings of lower 24-HC, 27-HC, and 7α-HC in MS compared to HC and higher 7-KC in P-MS compared to RR-MS indicate that the oxysterol network is disrupted in MS.
FellowsKUherTBrowneRW. Protective associations of HDL with blood brain barrier injury in multiple sclerosis patients. J Lipid Res2015; 10: 2010–2018.
2.
Weinstock-GuttmanBZivadinovRHorakovaD. Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event. J Neurol Neurosurg Psychiatry2013; 84(11): 1186–1191.
3.
ChenJCostaLGGuizzettiM.Assessment of cholesterol homeostasis in astrocytes and neurons. Methods Mol Biol2011; 758: 403–414.
4.
LeoniVCacciaC.24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases. Biochimie2013; 95(3): 595–612.
5.
VitaliCWellingtonCLCalabresiL.HDL and cholesterol handling in the brain. Cardiovasc Res2014; 103(3): 405–413.
6.
OlkkonenVMBeaslasONissilaE.Oxysterols and their cellular effectors. Biomol2012; 2(1): 76–103.
7.
PoliGBiasiFLeonarduzziG.Oxysterols in the pathogenesis of major chronic diseases. Redox Biol2013; 1: 125–130.
8.
GoldESDiercksAHPodolskyI. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. Proc Natl Acad Sci U S A2014; 111(29): 10666–10671.
9.
SpannNJGlassCK.Sterols and oxysterols in immune cell function. Nat Immunol2013; 14(9): 893–900.
10.
ZhornitskySMcKayKAMetzLM. Cholesterol and markers of cholesterol turnover in multiple sclerosis: Relationship with disease outcomes. Mult Scler Relat Disord2016; 5: 53–65.
11.
DolicKWeinstock-GuttmanBMarrK. Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PloS ONE2011; 6(11): e28062.
12.
NarayanaswamyRIyerVKhareP. Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS. PloS ONE2015; 10(4): e0123771.
13.
HelmschrodtCBeckerSThieryJ. Preanalytical standardization for reactive oxygen species derived oxysterol analysis in human plasma by liquid chromatography-tandem mass spectrometry. Biochem Biophys Res Commun2014; 446(3): 726–730.
14.
BrowneRWWeinstock-GuttmanBHorakovaD. Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. J Neurol Neurosurg Psychiatry2014; 85(8): 859–864.
15.
FriedewaldWTLevyRIFredricksonDS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem1972; 18(6): 499–502.
16.
BenjaminiYHochbergY.Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol1995; 57: 289–300.
17.
LublinFDReingoldSC.Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46(4): 907–911.
18.
LeoniVMastermanTDiczfalusyU. Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci Lett2002; 331(3): 163–166.
19.
TeunissenCEDijkstraCDPolmanCH. Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci Lett2003; 347(3): 159–162.
20.
PoliGBiasiFLeonarduzziG.Oxysterols in the pathogenesis of major chronic diseases. Redox Biol2013; 1(1): 125–130.
21.
GargiuloSSotteroBGambaP. Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: Implications regarding the vulnerability of atherosclerotic lesions. Free Radic Biol Med2011; 51(4): 844–855.
22.
GlassCKSaijoK.Immunology: Oxysterols hold T cells in check. Nature2008; 455(7209): 40–41.
23.
CuiGQinXWuL. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest2011; 121(2): 658–670.
24.
BensingerSJBradleyMNJosephSB. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell2008; 134(1): 97–111.
25.
ChalminFRochemontVLippensC. Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity. J Autoimmun2015; 56: 45–55.
26.
Weinstock-GuttmanBZivadinovRMahfoozN. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation2011; 8: 127.
27.
MandojCRennaRPlantoneD. Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis. Neurosci Lett2015; 606: 156–160.
28.
PalavraFMaradoDMascarenhas-MeloF. New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging. Dis Markers2013; 34(5): 341–348.
29.
TetteyPSimpsonSJrTaylorBV. Vascular comorbidities in the onset and progression of multiple sclerosis. J Neurol Sci2014; 347(1–2): 23–33.
30.
ChenYWangSYiZ. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci Rep2014; 4: 7242.
31.
CuiXKushiyamaAYonedaM. Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy. Diabetes Res Clin Pract2010; 87(1): 57–63.
32.
BovenLAVan MeursMVan ZwamM. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain2006; 129(Pt 2): 517–526.
33.
VandeKraatsCKillesteinJPopescuV. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Mult Scler2014; 20(4): 412–417.
34.
StilesARKozlitinaJThompsonBM. Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels. Proc Natl Acad Sci U S A2014; 111(38): E4006–E4014.
35.
ChancharmeLTherondPNigonF. LDL particle subclasses in hypercholesterolemia. Molecular determinants of reduced lipid hydroperoxide stability. J Lipid Res2002; 43(3): 453–462.
